Severe premature coronary artery disease with protease inhibitors

K Henry et al. Lancet. 1998.

. 1998 May 2;351(9112):1328.

doi: 10.1016/S0140-6736(05)79053-X.

No abstract available

Comment in

Vascular complications associated with use of HIV protease inhibitors.
Behrens G, Schmidt H, Meyer D, Stoll M, Schmidt RE. Behrens G, et al. Lancet. 1998 Jun 27;351(9120):1958. doi: 10.1016/S0140-6736(98)26026-0. Lancet. 1998. PMID: 9654284 No abstract available.
Vascular complications associated with use of HIV protease inhibitors.
Gallet B, Pulik M, Genet P, Chedin P, Hiltgen M. Gallet B, et al. Lancet. 1998 Jun 27;351(9120):1958-9. doi: 10.1016/S0140-6736(05)78643-8. Lancet. 1998. PMID: 9654285 No abstract available.
Vascular complications associated with use of HIV protease inhibitors.
Vittecoq D, Escaut L, Monsuez JJ. Vittecoq D, et al. Lancet. 1998 Jun 27;351(9120):1959. doi: 10.1016/s0140-6736(05)78644-x. Lancet. 1998. PMID: 9654286 No abstract available.
Vascular complications associated with use of HIV protease inhibitors.
Laurence J. Laurence J. Lancet. 1998 Jun 27;351(9120):1960. doi: 10.1016/S0140-6736(05)78645-1. Lancet. 1998. PMID: 9654287 No abstract available.
"Buffalo hump" in HIV-1 infection.
Stocker DN, Meier PJ, Stoller R, Fattinger KE. Stocker DN, et al. Lancet. 1998 Jul 25;352(9124):320-1. doi: 10.1016/S0140-6736(05)60295-4. Lancet. 1998. PMID: 9690434 No abstract available.